Recent Quotes (30 days)

You have no recent quotes
chg | %

Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 183   

Articles published

NVS 86.16 +1.22 (1.44%)
price chart
Here's The Real Importance Of The Latest Novartis AG (ADR) (NYSE:NVS) News
Novartis AG (ADR)(NVS) just announced that the Food and Drug Administration (FDA) in the US has approved one of its lead oncology development assets, a drug called Kymriah (CTL019), in a target indication of patients up to 25 years of age with B-cell ...
EPS for Novartis AG (ADR) (NVS) Expected At $1.25; Hsbc Holdings Plc Boosted ...
Analysts expect Novartis AG (ADR) (NYSE:NVS) to report $1.25 EPS on October, 24 before the open.They anticipate $0.02 EPS change or 1.63% from last quarter's $1.23 EPS.
Cambridge Trust Company Stake in Novartis Ag Sponsored Adr (NVS) Has Raised ...  WeeklyHub
3 Stocks to Watch on Tuesday: Boeing Co (BA), McDonald's Corporation (MCD) and ...
No investing took place yesterday due to Labor Day, which saw gasoline prices decline in the country. U.S. crude prices were mixed as several refineries were back in action as Hurricane Harvey exited most of the affected regions in Texas.
Novartis Lower Despite FDA Approval For Treatment Of Leukemia
Novartis AG (ADR) (NYSE: NVS) shares are trading lower by 80 cents at $82.82 in Wednesday's session. Despite FDA approval for CAR T-Cell therapy to treat certain children and young adults with B-cell acute Lymphoblastic Leukemia, the stock is in the red.
Novartis Wins FDA Approval for Groundbreaking Cancer Gene Therapy  Investorplace.com
Are Analysts Bearish Novartis AG (ADR) (NYSE:NVS) After Last Week?
Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Novartis Ag had 30 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Argus Research given on ...
Nelson Roberts Investment Advisors Has Decreased Its Novartis AG Spon Adr ...  FlintDaily.com
Novartis Ag (NVS) Stake Has Upped by Foyston Gordon & Payne Inc  Finance News Daily
Biotech Movers: Novartis AG (ADR) (NYSE:NVS), Otonomy, Inc. (NASDAQ:OTIC)
The first bit of news out of the market today in the biotechnology space is rooted in an approval just announced by biotechnology behemoth Novartis AG (ADR) (NYSE:NVS). The company announced on Wednesday that a drug called Kymriah (CTL019) ...
Wilkins Investment Counsel Increased Novartis Ag (Adr) (NVS) Holding By ...  UtahHerald.com
Nelson Roberts Investment Advisors Cut Its Novartis AG Spon Adr (NVS ...  Key Gazette
Everett Harris & Company Has Lowered Novartis AG Adr (NVS) Holding; General ...
Everett Harris & Company decreased Novartis A.G. Adr (NVS) stake by 7.19% reported in 2016Q4 SEC filing. Everett Harris & Company sold 4,485 shares as Novartis A.G. Adr (NVS)'s stock rose 4.17%. The Everett Harris & Company holds 57,888 shares with ...
Schafer Cullen Capital Management INC Stake in Novartis Ag (Adr) (NVS) Has ...  Finance News Daily
Cadence Design Systems (CDNS) Analysts See $0.24 EPS; First Financial Trimmed ...
First Financial Corp decreased Novartis Ag Spnsrd Adr (NVS) stake by 72.34% reported in 2017Q2 SEC filing. First Financial Corp sold 8,347 shares as Novartis Ag Spnsrd Adr (NVS)'s stock rose 4.17%. The First Financial Corp holds 3,191 shares with ...
Immunize Juno Therapeutics Inc (JUNO) Stock With This Trade
Novartis AG (ADR) (NYSE:NVS) recently secured the first-ever FDA approval for a CAR-T cancer therapy. As much and as InvestorPlace's James Brumley thoughtfully detailed earlier this week, the combined actions of Gilead and Novartis are significant for ...
Cadence Bank Na Lowered Its Novartis Ag Sponsored Adr (NVS) Position; Shorts ...
Cadence Bank Na decreased Novartis Ag Sponsored Adr (NVS) stake by 33.96% reported in 2016Q4 SEC filing. Cadence Bank Na sold 12,055 shares as Novartis Ag Sponsored Adr (NVS)'s stock rose 4.17%. The Cadence Bank Na holds 23,440 shares ...